GAD2 and type 1 diabetes mellitus: Menegaz and colleagues were able to establish that the islets of patients with T1D exhibit a significant reduction in GABA levels, which is not caused by a deficiency in GAD65 expression in β-cells, suggesting that loss of GABAergic signaling mechanisms may strongly correlate with T1D pathogenesis (Menegaz et al, 2019).